Insider · CIK 0001739054
Kim Kelderman
Files at CNMD (CONMED Corp), TECH (BIO-TECHNE Corp). First filing Jan 29, 2025, latest Jan 29, 2025.
In brief
Kim Kelderman files SEC Form 4 as CEO and director at TECH (BIO-TECHNE Corp), and also at CNMD (CONMED Corp). Since Jan 29, 2025, Kim Kelderman has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.0M, the latest filed on Jan 29, 2025.
A track record needs three past buys with six months of prices behind them; Kim Kelderman has 0, so none is measured yet.
The newest scored trade: sold $1.0M of TECH on Jan 27, 2025, filed Jan 29, 2025, scored 45 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TECH: BIO-TECHNE Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | TECHsell BIO-TECHNE Corp | $1.0M 13,392 shares | -26% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 27, 2025 | TECH BIO-TECHNE CORPORATION | 13,392 0.01% of outstanding | $1.0M | Jan 27, 2025 | none |
Transactions
Every row this insider has filed, 47 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | CNMD CONMED Corp | MOption exercise Common Stock | +500 | $0.00 | $0 | 500 | 33 d ago |
| Sep 8, 2026 | CNMD CONMED Corp | MOption exercise RSUs (Restricted Stock Units)derivative | -500 | $0.00 | $0 | 0 | 33 d ago |
| Aug 17, 2026 | TECH BIO-TECHNE Corp | AGrant or award Restricted Stock Unitsderivative | +57,590 | $0.00 | $0 | 57,590 | Aug 19, 2026 |
| Aug 17, 2026 | TECH BIO-TECHNE Corp | AGrant or award Restricted Stock Unitsderivative | +93,582 | $0.00 | $0 | 93,582 | Aug 19, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +21,470 | $0.00 | $0 | 93,583 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -10,821 | $72.40 | $783k | 82,762 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | MOption exercise Performance Restricted Stock Unitsderivative | -554 | $0.00 | $0 | 8,319 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | DDisposition to issuer Performance Restricted Stock Unitsderivative | -8,319 | $0.00 | $0 | 0 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | DDisposition to issuer Performance Stock Options (Right to Buy)derivative | -22,389 | $0.00 | $0 | 1,492 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | MOption exercise Performance Restricted Stock Unitsderivative | -588 | $0.00 | $0 | 8,835 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | DDisposition to issuer Performance Restricted Stock Unitsderivative | -8,835 | $0.00 | $0 | 0 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | DDisposition to issuer Performance Stock Options (Right to Buy)derivative | -24,324 | $0.00 | $0 | 1,621 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | MOption exercise Restricted Stock Unitsderivative | -8,543 | $0.00 | $0 | 8,544 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | MOption exercise Restricted Stock Unitsderivative | -11,785 | $0.00 | $0 | 23,569 | Aug 18, 2026 |
| Jul 28, 2026 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +35,000 | $47.60 | $1.7M | 100,799 | Jul 30, 2026 |
| Jul 28, 2026 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -28,686 | $72.07 | $2.1M | 72,113 | Jul 30, 2026 |
| Jul 28, 2026 | TECH BIO-TECHNE Corp | MOption exercise Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 30, 2026 |
| Jun 1, 2026 | CNMD CONMED Corp | AGrant or award RSUs (Restricted Stock Units)derivative | +5,772 | $0.00 | $0 | 5,772 | Jun 3, 2026 |
| May 5, 2026 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +26,692 | $47.60 | $1.3M | 89,750 | May 7, 2026 |
| May 5, 2026 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -23,951 | $56.68 | $1.4M | 65,799 | May 7, 2026 |
| May 5, 2026 | TECH BIO-TECHNE Corp | MOption exercise Stock Option (Right to Buy)derivative | -26,692 | $0.00 | $0 | 35,000 | May 7, 2026 |
| Apr 22, 2026 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +11,344 | $0.00 | $0 | 64,421 | Apr 24, 2026 |
| Apr 22, 2026 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -1,363 | $58.58 | $80k | 63,058 | Apr 24, 2026 |
| Apr 22, 2026 | TECH BIO-TECHNE Corp | MOption exercise Stock Option (Right to Buy)derivative | -11,344 | $0.00 | $0 | 61,692 | Apr 24, 2026 |
| Apr 14, 2026 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +36,500 | $0.00 | $0 | 85,165 | Apr 16, 2026 |
| Apr 14, 2026 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -32,088 | $58.66 | $1.9M | 53,077 | Apr 16, 2026 |
| Apr 14, 2026 | TECH BIO-TECHNE Corp | MOption exercise Stock Option (Right to Buy)derivative | -36,500 | $0.00 | $0 | 73,036 | Apr 16, 2026 |
| Nov 3, 2025 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -2,303 | $62.57 | $144k | 48,665 | Nov 5, 2025 |
| Sep 8, 2025 | CNMD CONMED Corp | AGrant or award RSUs (Restricted Stock Units)derivative | +500 | $0.00 | $0 | 500 | Sep 9, 2025 |
| Sep 8, 2025 | CNMD CONMED Corp | AGrant or award Options To Purchase Common Stockderivative | +6,227 | $0.00 | $0 | 6,227 | Sep 9, 2025 |
| Aug 15, 2025 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +8,543 | $0.00 | $0 | 55,273 | Aug 19, 2025 |
| Aug 15, 2025 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -4,305 | $53.60 | $231k | 50,968 | Aug 19, 2025 |
| Aug 15, 2025 | TECH BIO-TECHNE Corp | MOption exercise Restricted Stock Unitsderivative | -8,543 | $0.00 | $0 | 17,087 | Aug 19, 2025 |
| Aug 15, 2025 | TECH BIO-TECHNE Corp | AGrant or award Performance Restricted Stock Unitsderivative | +70,708 | $0.00 | $0 | 70,708 | Aug 19, 2025 |
| Aug 15, 2025 | TECH BIO-TECHNE Corp | AGrant or award Restricted Stock Unitsderivative | +35,354 | $0.00 | $0 | 35,354 | Aug 19, 2025 |
| Aug 15, 2025 | TECH BIO-TECHNE Corp | AGrant or award Stock Options (Right to Buy)derivative | +90,441 | $0.00 | $0 | 90,441 | Aug 19, 2025 |
| Jul 22, 2025 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +48,176 | $44.33 | $2.1M | 90,379 | Jul 24, 2025 |
| Jul 22, 2025 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -43,649 | $53.12 | $2.3M | 46,730 | Jul 24, 2025 |
| Jul 22, 2025 | TECH BIO-TECHNE Corp | MOption exercise Stock Option (Right to Buy)derivative | -48,176 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 15, 2025 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +36,132 | $44.33 | $1.6M | 75,136 | Jul 17, 2025 |
| Jul 15, 2025 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -32,933 | $51.42 | $1.7M | 42,203 | Jul 17, 2025 |
| Jul 15, 2025 | TECH BIO-TECHNE Corp | MOption exercise Stock Option (Right to Buy)derivative | -36,132 | $0.00 | $0 | 48,176 | Jul 17, 2025 |
| Jan 27, 2025 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +13,392 | $37.70 | $505k | 52,396 | Jan 29, 2025 |
| Jan 27, 2025 | TECH BIO-TECHNE Corp | SOpen-market sale Common Stock | -11,731 | $77.19 | $906k | 40,665 | Jan 29, 2025 |
| Jan 27, 2025 | TECH BIO-TECHNE Corp | SOpen-market sale Common Stock | -1,661 | $77.95 | $129k | 39,004 | Jan 29, 2025 |
| Jan 27, 2025 | TECH BIO-TECHNE Corp | MOption exercise Stock Option (Right to Buy)derivative | -13,392 | $0.00 | $0 | 0 | Jan 29, 2025 |
| Nov 1, 2024 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -2,430 | $75.31 | $183k | 39,004 | Nov 5, 2024 |
Questions about Kim Kelderman
Answered from the filings on this page, as of the latest one.
Is Kim Kelderman buying or selling?
Not in the last 12 months. Kim Kelderman's latest open-market trade on SEC Form 4 was sold $1.0M of TECH on Jan 27, 2025.
How did Kim Kelderman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kim Kelderman has 0.
Where does Kim Kelderman file Form 4?
Kim Kelderman has filed Form 4 at TECH (BIO-TECHNE Corp) as Chief Executive Officer; CNMD (CONMED Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.